NUCLERA
Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis. Nuclera has since grown to fifty-seven employees across two continents as the Company delivers on its founders’ vision to make biology accessible to everyone through desktop bioprinting. With desktop bioprinting, researchers and scientists will be empowered to take control of biology through streamlined access to a next-day supply of proteins and genes.
NUCLERA
Industry:
Biotechnology Industrial Engineering Life Science Pharmaceutical
Founded:
2013-08-27
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.nuclera.com
Total Employee:
11+
Status:
Active
Total Funding:
69.35 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network ReCAPTCHA Cloudflare JS CDN JS COVID-19
Similar Organizations
Fluidic Analytics
Fluidic Analytics designs, develops and manufactures tools that seek to revolutionise the way proteins are characterised.
Holiferm
Holiferm develops holistically improved fermentation technology for massive economic improvements.
Onego Bio
Onego Bio is a smart protein is a piece of cake.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-05-12 | E Ink -Digital Microfluidics Business | E Ink -Digital Microfluidics Business acquired by Nuclera | N/A |
Investors List
Verve Ventures
Verve Ventures investment in Series B - Nuclera
Jonathan Milner
Jonathan Milner investment in Series B - Nuclera
G. K. Goh
G. K. Goh investment in Series B - Nuclera
Future Planet Capital
Future Planet Capital investment in Series B - Nuclera
Amadeus Capital Partners
Amadeus Capital Partners investment in Series B - Nuclera
British Business Bank
British Business Bank investment in Series B - Nuclera
RT Partners
RT Partners investment in Series B - Nuclera
M&G Investments
M&G Investments investment in Series B - Nuclera
E Ink
E Ink investment in Series B - Nuclera
Official Site Inspections
http://www.nuclera.com Semrush global rank: 3.36 M Semrush visits lastest month: 4.72 K
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Nuclera"
About us - Nuclera
The British Business Bank and E Ink -- a Nuclera strategic partner -- invests $12M into Nuclera through the UK Future Fund. 2021 Nuclera acquires digital microfluidic intellectual property, equipment, and team from its strategic …See details»
Nuclera - Crunchbase Company Profile & Funding
Organization. Nuclera . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Nuclera offers a …See details»
Our Team - Nuclera
Nuclera is on a mission to better human health by making proteins accessible. Meet the people guiding our approach including our global leadership team, board members and scientific …See details»
Nuclera - Lab Manager
Jun 25, 2021 Nuclera Nuclera is the leading pioneer in making biology accessible through desktop enzymatic protein and gene synthesis. Headquartered in Cambridge, UK, Nuclera …See details»
Nuclera - LinkedIn
Nuclera | 15,910 followers on LinkedIn. Bring rapid protein access to your benchtop with eProtein Discovery | At Nuclera, our mission is to better human health by making proteins accessible. We ...See details»
Nuclera 2025 Company Profile: Valuation, Funding & Investors
Nuclera General Information Description. Developer of an automated construct platform designed to power up drug discovery workflows. The company allows researchers to accelerate their …See details»
Nuclera Corporation Company Profile | Billerica, MA | Competitors ...
Find company research, competitor information, contact details & financial data for Nuclera Corporation of Billerica, MA. Get the latest business insights from Dun & Bradstreet.See details»
Nuclera Company Profile - Office Locations, Competitors ... - Craft
Nuclera is a company that specializes in DNA synthesis. It develops a platform enabling the production of accurate, ultra-long DNA and genome libraries for protein, biological pathway, …See details»
Nuclera - VentureRadar
Nuclera is a next-generation DNA synthesis company creating solutions for the synthetic biology, industrial enzyme engineering, and pharmaceutical industries. Our proprietary enzyme …See details»
Nuclera announces key leadership appointments to drive protein ...
I continue to look forward to the tremendous opportunity to shape the culture, support growth, and create a positive impact across the organization.” Addressing the protein accessibility …See details»
Nuclera - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Nuclera . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Nuclera has 3 current employee profiles, including Co …See details»
Nuclera Expands Global Footprint with New Distribution …
4 days ago At Nuclera, we are excited to announce that we have established a distribution network across the Asia-Pacific (APAC) region and the Middle East. This milestone marks a …See details»
Nuclera - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Nuclera - Cambridge Judge Business School
Nuclera is a US and UK-based biotechnology company driven by the mission to better human health by making proteins accessible. Nuclera is enabling life science researchers to obtain …See details»
Nuclera - Technology Networks
Nuclera, and Domainex, announced that Domainex is the first contract research organization (CRO) to have installed the eProtein Discovery system and offer protein production services …See details»
Nuclera to scale in US and Europe after closing $75m Series C
Oct 16, 2024 Nuclera’s eProtein Discovery system is designed to speed up protein expression and purification in research labs, including those using AI for protein design. The system is …See details»
Nuclera eProtein Discovery system installed at leading academic ...
May 2, 2024 Dr Michael Chen, CEO and co-founder, Nuclera, said: “The commercial launch of our eProtein Discovery platform and placement in leading academic institutes marks a key …See details»
Nuclera Establishes Distribution Network Across APAC and the …
3 days ago CAMBRIDGE, England & BOSTON, May 06, 2025--Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein …See details»
Nuclera to scale in US and Europe after closing $75m Series C
Oct 15, 2024 Nuclera’s eProtein Discovery system is designed to speed up protein expression and purification in research labs, including those using AI for protein design. The system is …See details»
News - Nuclera
4 days ago Nuclera’s eProtein Discovery system installed at Domainex to streamline protein production services . November 4, 2024. Investor News . Nuclera closes $75 million USD …See details»